BERGENBIO LIMITED
Company number 10555293 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£191
Balance sheet as at 2025-12-31
What it does
The company is involved in research and development in the biotechnology sector.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-01-10
- Employees
- 5 (2025 accounts · was 10 in 2024)
- Registered office
- 8 King Edward Street, Oxford, United Kingdom, OX1 4HL
- Postcode
- OX1 4HL
- Capital
- 100 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-01-09
- Next due by
- 2027-01-23
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 3 resigned
Group structure
Controlled by Bergenbio Asa (99221968) — since 2017-01-10
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Global Business Mobility: Senior or Specialist Worker (Worker (A rating)), Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Contact details
- Website
- bergenbio.com
- Phone
- +44 1865784588
BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers
Competitors Oxford
This company ranks 130 among research and experimental development on biotechnology in Oxford.
The class of 2017
36%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.